Skip to main content
Fig. 3 | Experimental Hematology & Oncology

Fig. 3

From: Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review

Fig. 3

Representative examples of the main strategies to produce antitumour allogeneic CAR-T cells: (A) Performing additional genetic modifications (besides CAR transgene introduction) on donor αβ T cells, or using different cell sources such as (B) γδ T cells, (C) induced pluripotent stem cells (iPSCs), (D) umbilical cord blood T cells, (E) central memory T cells, or (F) virus-specific T cells. Created with BioRender.com.

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us